Absolutely!Because fauci and his buddies had stock in Remdisivir. The proof is out there in black and white. This was all money laundering and wealth redistribution. It had nothing to do with a virus.
Horowitz: The FDA wants to steal our safe drugs while mandating dangerous ones
At a time when the federal government is mandating dangerous, experimental products upon us that are absolved of all liability, it is also seeking to ban fully established, safe drugs that are absolutely on the hook for liability. The same government agencies that fund, market, distribute, and...
www.conservativereview.com
“At a time when the federal government is mandating dangerous, experimental products upon us that are absolved of all liability, it is also seeking to ban fully established, safe drugs that are absolutely on the hook for liability. The same government agencies that fund, market, distribute, and indemnify mRNA shots, Paxlovid, and remdesivir are also the judge, jury, and executioner of their competition! Meanwhile, the FDA gets to share in royalties of Moderna, paying the “regulators” even higher salaries to continue doing the same. Have you ever heard of such a genocidal pay-for-play, conflict of interest, and fascism perpetrated against our individual health?
One of the most shocking yet revealing dynamics that played out under COVID fascism was when the federal and state governments started quietly encouraging pharmacists to block valid prescriptions for ivermectin and hydroxychloroquine and even for budesonide and antibiotics to treat COVID. The FDA famously tweeted out, “You are not a horse … y’all” in August 2021, in an attempt to mislead the public into thinking there was no human form of ivermectin. New documents show that FDA comms staff were congratulating themselves on a job well done.
Several weeks ago, I identified a provision on page 3,542 of the infamous fiscal year 2023 omnibus bill that seems to give the FDA authority to ban the use of medical devices for off-label purposes, a concern first raised by Dr. Joel Zinberg, associate clinical professor of surgery at the Icahn School of Medicine, in the Wall Street Journal.”